Healthcare entity
Every one of those 1 sits in a single category, market-trends. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. is most often covered alongside Collegium Pharmaceutical, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd., all published on August 9, 2026.
Last mentioned: Aug 16, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, market-trends. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. is most often covered alongside Collegium Pharmaceutical, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd., all published on August 9, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 11 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.. Shared-story counts are live from our verified record — not editorial picks.
Collegium Pharmaceutical's Q2 2026 earnings beat signals sustained demand for its abuse-deterrent pain medications. Revenue grew 6.3% to $199.88M, and EPS of $1.92 surpassed forecasts by $0.20, indicating commercial strength despite regulatory pressures.
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
